Cargando…

Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus

Diabetic macroangiopathy, atherosclerosis secondary to diabetes mellitus (DM), causes cerebro-cardiovascular diseases, which are major causes of death in patients with DM and significantly reduce their quality of life. The alterations in vascular homeostasis due to endothelial and vascular smooth mu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Katakami, Naoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770221/ https://www.ncbi.nlm.nih.gov/pubmed/28966336 http://dx.doi.org/10.5551/jat.RV17014

Ejemplares similares

Carotid ultrasonography: A potent tool for better clinical practice in diagnosis of atherosclerosis in diabetic patients
por: Katakami, Naoto, et al.
Publicado: (2014)

Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis
por: Kaneto, Hideaki, et al.
Publicado: (2010)

Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis
por: Mita, Tomoya, et al.
Publicado: (2017)

Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
por: Kaneto, Hideaki, et al.
Publicado: (2020)

Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus
por: Mita, Tomoya, et al.
Publicado: (2017)

Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management
por: Katsi, Vasiliki, et al.
Publicado: (2023)

From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes
por: Osawa, Saeko, et al.
Publicado: (2017)

Disturbances of Haemostasis in Diabetes Mellitus Contributing to the Development of Atherosclerosis
por: Stegnar, Mojca
Publicado: (2002)

Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

Immunity, atherosclerosis and cardiovascular disease
por: Frostegård, Johan
Publicado: (2013)

Atherosclerosis and Thrombosis in Diabetes Mellitus
por: Rukavi, Ana Stavlenić
Publicado: (2002)

Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3
por: Ye, Jingxue, et al.
Publicado: (2022)

The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases
por: Sanchez-Rodriguez, Estefania, et al.
Publicado: (2020)

Atherosclerosis and Cardiovascular Diseases in Progeroid Syndromes
por: Kato, Hisaya, et al.
Publicado: (2022)

MicroRNAs and Cardiovascular Disease in Diabetes Mellitus
por: Ding, Yue, et al.
Publicado: (2017)

The Mechanisms of the Development of Atherosclerosis in Prediabetes
por: Liang, Yin, et al.
Publicado: (2021)

Different impacts of metabolic profiles on future risk of cardiovascular disease between diabetes with and without established cardiovascular disease: the Japan diabetes complication and its prevention prospective study 7 (JDCP study 7)
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021)

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial
por: Katakami, Naoto, et al.
Publicado: (2023)

Clinical utility of carotid ultrasonography: Application for the management of patients with diabetes
por: Katakami, Naoto, et al.
Publicado: (2019)

Correction to: Different impacts of metabolic profiles on future risk of cardiovascular disease between diabetes with and without established cardiovascular disease: the Japan diabetes complication and its prevention prospective study 7 (JDCP study 7)
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021)

Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk
por: Colom, Cristina, et al.
Publicado: (2021)

Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes
por: Ninomiya, Hiroyo, et al.
Publicado: (2018)

Diabetes Mellitus and Cardiovascular Disease
por: Aganovic, Izet
Publicado: (2003)

Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases
por: Ji, Eunhye, et al.
Publicado: (2021)

Assessment of vibratory sensation with a tuning fork at different sites in Japanese patients with diabetes mellitus
por: Takahara, Mitsuyoshi, et al.
Publicado: (2014)

The Role of Zinc Homeostasis in the Prevention of Diabetes Mellitus and Cardiovascular Diseases
por: Tamura, Yukinori
Publicado: (2021)

The Role of Echocardiography in Evaluating Cardiovascular Diseases in Patients with Diabetes Mellitus
por: Lee, Sun Hwa, et al.
Publicado: (2023)

Porcine Models of Accelerated Coronary Atherosclerosis: Role of Diabetes Mellitus and Hypercholesterolemia
por: Hamamdzic, Damir, et al.
Publicado: (2013)

Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2023)

The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation
por: Poznyak, Anastasia, et al.
Publicado: (2020)

Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus
por: Colaiori, Iginio, et al.
Publicado: (2019)

Characteristic changes in plasma glutamate levels and free amino acid profiles in Japanese patients with type 1 diabetes mellitus
por: Kawamori, Dan, et al.
Publicado: (2022)

The regulator of calcineurin (RCAN1) an important factor involved in atherosclerosis and cardiovascular diseases development
por: Torac, E, et al.
Publicado: (2014)

Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease
por: Frąk, Weronika, et al.
Publicado: (2022)

The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases
por: Wójcik-Cichy, Kamila, et al.
Publicado: (2018)

Application of Metabolomics to Epidemiological Studies of Atherosclerosis and Cardiovascular Disease
por: Iida, Miho, et al.
Publicado: (2019)

The Complex Tail of Circulating Sphingolipids in Atherosclerosis and Cardiovascular Disease
por: Zelnik, Iris D., et al.
Publicado: (2021)

Salivary metabolic signatures of carotid atherosclerosis in patients with type 2 diabetes hospitalized for treatment
por: Sakanaka, Akito, et al.
Publicado: (2022)

Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus
por: Fujihara, Kazuya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8mdrq40ble71k2p9bp7rsf53tr